bioAffinity Technologies, Inc. (BIAF) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 113 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jul 1, 2024 involved a transaction of 33,784 shares valued at $0.
No significant insider buying has been recorded for BIAF in the recent period.
No significant insider selling has been recorded for BIAF in the recent period.
Based on recent SEC filings, insider sentiment for BIAF is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at bioAffinity Technologies, Inc. (BIAF) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading BIAF stock, having executed 113 transactions in the past 90 days. The most active insider is Sandler Revocable Trust Harvey (Executive), who has made 12 transactions totaling $3.5M.
Get notified when executives and directors at BIAF file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | Joyce Roby | Executive | Award | 33,784 | $N/A | $0 | |
| Jul 1, 2024 | Zannes Maria | Executive | Award | 33,784 | $N/A | $0 | |
| Jul 1, 2024 | D. Rubin Gary | Executive | Award | 33,784 | $N/A | $0 | |
| Jul 1, 2024 | Platt Jamie | Executive | Award | 33,784 | $N/A | $0 | |
| Jul 1, 2024 | S. Knight Peter | Executive | Award | 33,784 | $N/A | $0 | |
| Jul 1, 2024 | A. Anderson Robert | Executive | Award | 33,784 | $N/A | $0 | |
| Jul 1, 2024 | Diamond Stuart | Executive | Award | 33,784 | $N/A | $0 | |
| Jul 1, 2024 | Girgenti Steven | Executive | Award | 33,784 | $N/A | $0 | |
| Jun 12, 2024 | S. Knight Peter | Executive | Award | 8,296 | $N/A | $0 | |
| Jun 12, 2024 | A. Anderson Robert | Executive | Award | 8,296 | $N/A | $0 | |
| Jun 12, 2024 | Joyce Roby | Executive | Award | 8,296 | $N/A | $0 | |
| Jun 12, 2024 | Zannes Maria | Executive | Award | 8,296 | $N/A | $0 | |
| Jun 12, 2024 | Platt Jamie | Executive | Award | 8,296 | $N/A | $0 | |
| Jun 12, 2024 | Girgenti Steven | Executive | Award | 8,296 | $N/A | $0 | |
| Jun 12, 2024 | Diamond Stuart | Executive | Award | 8,296 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 29 | $6.8M | 81.4% |
Award(A) | 70 | $1.0M | 12.3% |
Exercise(M) | 4 | $300.9K | 3.6% |
Payment(F) | 3 | $224.7K | 2.7% |
Purchase(P) | 7 | $0 | 0.0% |
Insider activity at bioAffinity Technologies, Inc. shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.17 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Sandler Revocable Trust Harvey, has transacted $3.5M during this period.